R. Baxter

Measurement of the acid-labile subunit of the insulin-like growth factor binding protein complex in human serum: a comparison of four immunoassays.

R. Baxter, V. Quarmby, J. Mistry, 2000, The Journal of endocrinology.

Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.

R. Baxter, S. Stranks, A. Corbould, 1995, The Journal of clinical endocrinology and metabolism.

IGFBP-3 binds GRP78, stimulates autophagy and promotes the survival of breast cancer cells exposed to adverse microenvironments

R. Baxter, S. Firth, S. Grkovic, 2013, Oncogene.

Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.

R. Baxter, S. Pattison, J. Martín, 1995, Endocrinology.

Effects of insulin‐like growth factor I treatment on the molecular distribution of insulin‐like growth factors among different binding proteins

J. Guevara-Aguirre, R. Rosenfeld, M. Vaccarello, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Phosphorylation of insulin-like growth factor binding proteins

R. Baxter, J. Coverley, R. Baxter, 1997, Molecular and Cellular Endocrinology.

Insulin-like growth factor-binding protein-3 is functionally normal in pregnancy serum.

R. Baxter, A. Suikkari, R. Baxter, 1992, The Journal of clinical endocrinology and metabolism.

Complex formation by human insulin-like growth factor-binding protein-3 and human acid-labile subunit in growth hormone-deficient rats.

R. Baxter, M. Lewitt, J. Phuyal, 1994, Endocrinology.

The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus.

D. Dunger, R. Baxter, J. Holly, 1998, The Journal of endocrinology.